FDA.reportPublic FDA data

Exoden Powder

Product NDC
70602-003
Requested package NDC
70602-003-02
11-digit product format
706020003
Labeler code
70602
Product ID
70602-003_bd24d050-20b3-26d4-e053-2995a90a05b5
Type
HUMAN OTC DRUG
Nonproprietary name
Cetylpyridinium Chloride, Domiphen Bromide
Dosage form
POWDER
Route
TOPICAL
Labeler
LIFEON Corp.
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2021-03-09
Marketing end
0000-00-00
Substance
DOMIPHEN BROMIDE; CETYLPYRIDINIUM CHLORIDE
Active strength
0 1/100g; g/100g
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage70602-00370602-003-02IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31UExcluded because listing certification expired302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20UExcluded because listing certification expireded331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10UExcluded because listing certification expired0efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70602-003-022025-01-30C16284748780-12cef2736-7a46-d83d-e063-dadaa90ab31f70602-003_Exoden Powder
70602-003-042025-01-30C16284748780-12cef2736-7a46-d83d-e063-dadaa90ab31f70602-003_Exoden Powder
70602-003-062025-01-30C16284748780-12cef2736-7a46-d83d-e063-dadaa90ab31f70602-003_Exoden Powder

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70602-003-01Exoden Powder10 g in 1 POUCHPOWDER101
70602-003-02Exoden Powder1 in 1 CARTONPOWDER11
70602-003-03Exoden Powder30 g in 1 CONTAINERPOWDER301
70602-003-04Exoden Powder1 in 1 CARTONPOWDER11
70602-003-05Exoden Powder70 g in 1 CONTAINERPOWDER701
70602-003-06Exoden Powder1 in 1 CARTONPOWDER11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70602-003EXODEN POWDER (CETYLPYRIDINIUM CHLORIDE, DOMIPHEN BROMIDE) POWDER [LIFEON CORP.]1Legacy NDC, 6 package rows20210311_b6ce8178-fe76-49b9-adb7-b06fe67df2a3.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70602-003-02706020003021 POUCH in 1 CARTON (70602-003-02) > 10 g in 1 POUCH (70602-003-01) 1 pouch2021-03-090000-00-00NoNoCurrent